News View all news
Shorter duration opioid prescriptions plus education could be better for patients after surgery
A small study could have big insights for opioid use after surgery. Greater opioid quantity for postsurgery patients has been associated with the development of addiction, noted authors of a study published in JAMA on June 25. Their study looked at whether reducing the number of opioid tablets prescribed after anterior cruciate ligament (ACL) knee surgery at a single academic ambulatory surgery center would reduce postoperative use, and if preoperative opioid-use education could reduce it even more.
With summer here, CDC reminds travelers to be up to date on MMR
With cases of measles continuing to climb in the United States and Americans embarking on summer travel, CDC is reminding health care practitioners and the public about MMR vaccination recommendations for international travelers as well those traveling to U.S. areas with ongoing measles outbreaks.
New treatment for osteoporosis in postmenopausal women with high fracture risk
FDA approved a new treatment, romosozumab-aqqg (Evenity—Amgen), for osteoporosis in postmenopausal women at high risk of fracture, such as those who have a history of osteoporotic fracture or have multiple risk factors for fracture, as well as patients who are intolerant to or have not had success with other osteoporosis therapies. Romosozumab-aqqg is a humanized monoclonal antibody that increases new bone formation by blocking the effects of sclerostin, a protein that inhibits bone formation.
FDA expands approval of CF treatment to include patients ages 6 and older
FDA has expanded the indication for tezacaftor/ivacaftor (Symdeko—Vertex) tablets for the treatment of patients aged 6 years and older with cystic fibrosis who have two copies of the F508del mutation in the CF transmembrane conductance regulator gene or at least one mutation that is responsive to tezacaftor/ivacaftor.
June 13, 2019
Chapter Two: Imagine the opportunities
Note from Tom: In honor of his emphasis on the power of stories to advance pharmacists’ professional status, APhA President Brad Tice is contributing a monthly guest blog on the topic. Enjoy the…0 comments
June 18, 2019
APhA Accepting Nominations for 2020 Annual Awards and Honors Program
Nominations are now being accepted for the American Pharmacists Association (APhA) annual awards and honors program. The awards will be presented at the APhA Annual meeting and Exposition in Washington, DC, March 20-23, 2020. The APhA awards and honors program is the most comprehensive recognition program in the profession of pharmacy.
June 11, 2019
Pharmacy Profiles Launches the Nation’s First One-Stop Repository of Pharmacists’ Credentials and Professional Information
Pharmacy Profiles, the trusted and verified repository of the nation's pharmacist providers, today announces its nationwide launch. A subsidiary of the American Pharmacists Association, Pharmacy Profiles provides a one-stop repository of all of the professional information a pharmacist would need to achieve and maintain full recognition as a health care provider. It will support the nation's pharmacists in unlocking their full potential as trusted health care providers and members of the health care team.
APhA is the leading advocate for the pharmacy profession and a driving force in creating opportunities for pharmacists to play a key role in integrated patient care, and ensuring the profession is recognized as essential in optimal medication use. We strive to make your job as a pharmacist easier, by providing the latest industry news, continuing education and professional development opportunities, practice tools, and more, so that you can focus on caring for your patients.